RFA-AI-19-065: Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) - 0 views
-
MiamiOH OARS on 15 Oct 19This initiative will support basic and/or translational research to address knowledge gaps that hinder the development and regulation of bacteriophage used to prevent and treat bacterial infections. While individual phage products may be used to assess the research questions, the primary intent is to increase the overall knowledge base on bacteriophage as products. NIAID offers other funding mechanisms for the preclinical and clinical development of phage and other non-traditional antibiotic products.